World of DTC Marketing

APRIL 22, 2021

QUICK READ: More TV DTC spots are airing, but DTC marketers are losing the battle between awareness and conversion because of all the noise online. I’ve spent the last six months analyzing clients’ DTC marketing campaigns and they are, for most ineffective. One of the most underused tactics is your product website.

Marketing 265

Marketing Doctors Doctor Production 265

Bio Pharma Dive

AUGUST 7, 2024

Quarterly revenue from Ozempic and Wegovy missed Wall Street estimates by about 9%, concerning some analysts and causing a stock sell-off costing the Danish drugmaker tens of billions in market value.

Sales 276

Sales Drugs Marketing 276

World of DTC Marketing

JULY 21, 2021

SUMMARY: DTC marketing is not the reason why prescription drugs cost so much. The voices in Washington DC are once again calling for a moratorium on DTC marketing but lawmakers need to understand what DTC marketing actually does as upped to what people believe it does. DTC ads raise awareness around health conditions.

Marketing 285

Marketing Doctor Doctors Drugs 285

World of DTC Marketing

NOVEMBER 16, 2021

SUMMARY: Omnichannel marketing employs the simultaneous implementation of channels across personal, non-personal, and media and addresses the integrated needs of multiple stakeholders – consumers/patients, healthcare professionals, and payers. Today there are microsegments of markets, and one message shouldn’t be used for all.

Marketing 253

Marketing Doctor Doctors Sales 253

Bio Pharma Dive

JULY 29, 2022

Imbruvica, long one of AbbVie’s top-selling medicines, has ceded market share in treating chronic lymphocytic leukemia to AstraZeneca’s Calquence.

Sales 290

Sales Medicine Drugs Marketing 290

Pharmaceutical Technology

OCTOBER 18, 2024

Late-stage pipeline products could drive combined sales of approximately $171.4 million by 2033 in the 8MM.

Sales 269

Sales Marketing Production 269

Bio Pharma Dive

DECEMBER 5, 2022

The positive results could help Novartis secure approval for earlier use of the radiopharmaceutical drug Pluvicto, potentially broadening the number of eligible patients by several times the current market.

Sales 297

Sales Drugs Marketing 297

Bio Pharma Dive

JULY 9, 2021

Zynteglo sales have been on hold since February, when a patient in a clinical trial of another, related Bluebird medicine developed leukemia.

Gene Therapy 271

Gene Therapy Gene Marketing Clinical Trials 271

Bio Pharma Dive

MARCH 13, 2023

In its first full quarter on the market, Amylyx’s Relyvrio generated revenue just shy of $22 million, or roughly five times what some analysts were forecasting a month ago.

Sales 238

Sales Drugs Marketing 238

Bio Pharma Dive

OCTOBER 21, 2022

The company is considering charging as much as between $110 and $130 per dose — roughly four times the vaccine’s current price — once sales transition to the private market.

Vaccination 349

Vaccination Vaccine Sales Marketing 349

Bio Pharma Dive

OCTOBER 13, 2023

Sales of Pfizer's antiviral Paxlovid and shot Comirnaty have been slower than it anticipated, while a shift to the commercial market for the antiviral has been delayed.

Production 343

Production Sales Marketing 343

Pharmaceutical Technology

JULY 26, 2022

According to GlobalData’s recent Niemann-Pick Type C (NPC): Opportunity Analysis and Forecast to 2031 report, the NPC market is expected to see significant growth during 2021–31. This sales growth will be in line with a steadily increasing disease prevalence and the entrance of novel agents into the market.

Marketing 306

Marketing Gene Branding Clinical Development 306

Pharmaceutical Technology

NOVEMBER 14, 2024

Discover the top sales and marketing intelligence solutions tailored for the pharmaceutical industry. Download our guide to predictive analytics and data-driven insights.

Sales 130

Sales Marketing 130

World of DTC Marketing

APRIL 6, 2022

DTC marketing has evolved. Challenge #1 – DIGITAL MARKETING. Pharma companies are increasing digital budgets, but they are wasting too much money because of internal staffing issues and inexperience with online marketing. Paid Media – The most commonly used KPI in marketing is essentially worthless.

Marketing 196

Marketing Sales Pharma Companies Doctors 196

World of DTC Marketing

APRIL 20, 2022

We just finished talking to over 200 hundred HCPs about pharma marketing and salespeople to measure any differences since before the pandemic. ” We heard more negative comments than positive ones from sales reps, even in Oncology. This was especially true with new drugs that have a significant competitive market.

Marketing 218

Marketing Drugs Drug Trials Sales 218

Bio Pharma Dive

JANUARY 31, 2023

The company expects yearly revenue from Comirnaty and Paxlovid to fall by nearly two thirds in 2023 amid lower vaccination rates and a shift to private market sales.

Sales 164

Sales Vaccination Vaccine Drugs 164

Pharmaceutical Technology

NOVEMBER 7, 2024

Discover the top sales and marketing intelligence providers for the pharmaceutical industry, offering predictive insights and data enrichment to drive growth.

Sales 130

Sales Marketing 130

Pharmaceutical Technology

MAY 14, 2024

Bayer announced a fall in Q1 sales and predicted future challenges in the Xarelto market in its Q1 update.

Sales 147

Sales Marketing 147

AuroBlog - Aurous Healthcare Clinical Trials blog

SEPTEMBER 14, 2022

The medical devices industry in the country has sought the Centre to define online and offline mode of sale, provide more clarity on the regulations that are binding the online sales and suggested inclusion of online medical devices players under the Uniform Code for Medical Devices Marketing Practices (UCMDMP).

Sales 182

Sales Regulation Marketing Drugs 182

Pharmaceutical Technology

DECEMBER 9, 2022

Brazil is the largest country in Latin America, with a population of over 212 million, and consequently has the biggest pharmaceutical market in the region. Pharmaceutical sales in Brazil reached $17bn in 2021, according to GlobalData figures. The generics market in Brazil. by 2040 based on statistics from OECD.

Marketing 246

Marketing Sales Production Medicine 246

Pharmaceutical Technology

JANUARY 17, 2025

Discover the leading sales intelligence tools & solutions for the pharmaceutical industry. Download the free Buyer's Guide for contact details.

Sales 130

Sales Marketing 130

Pharma Mirror

JUNE 23, 2023

In the fast-paced, highly competitive pharmaceutical industry, sales reps must adapt to new ways of engaging with customers and healthcare professionals (HCPs).

Sales 130

Sales Development Marketing 130

Pharmaceutical Technology

JANUARY 25, 2023

It was an exceptional year for Moderna’s vaccine Spikevax, with forecast sales of $19.5bn in 2022. Currently, Spikevax is the second bestselling Covid-19 vaccine behind Pfizer’s Comirnaty, which is in the leading position, with forecast sales of $37bn in 2022.

Sales 147

Sales Vaccination Vaccine Marketing 147

Bio Pharma Dive

OCTOBER 29, 2024

New guidelines and the timing of COVID vaccinations impacted uptake of Abrysvo this year, according to a company executive.

Vaccination 164

Vaccination Vaccine Sales Marketing 164

Pharma Marketing Network

MARCH 26, 2025

Artificial intelligence (AI) is no longer a futuristic concept in healthcareits here, embedded in nearly every touchpoint of modern pharma marketing. But as pharma marketers race to adopt these tools, a central question looms: Is AI fueling smarter engagement, or setting the stage for a compliance disaster?

Compliance 64

Compliance Marketing Regulation Pharma Companies 64

Bio Pharma Dive

OCTOBER 23, 2024

Elsewhere, Sangamo plotted a much faster path to market for its Fabry gene therapy. Yale spinout Modifi agreed to sell to Merck for $30 million upfront.

Gene Therapy 187

Gene Therapy Sales Gene Drugs 187

Pharmaceutical Technology

NOVEMBER 20, 2024

Discover leading sales enablement and marketing intelligence solutions tailored for the pharmaceutical industry. Download our guide to market forecasts and industry insights.

Sales 130

Sales Marketing 130

Bio Pharma Dive

AUGUST 11, 2022

The companies could face liability related to their sales of the heartburn drug, which was withdrawn from market in the U.S. and other countries after impurities related to a likely carcinogen were detected.

Sales 281

Sales Marketing Drugs 281

Pharmaceutical Technology

OCTOBER 24, 2024

The opioid addiction treatment market will be worth $2.4bn by 2033, driven by diagnoses in the eight major world markets.

Marketing 130

Marketing Sales 130

pharmaphorum

MAY 8, 2024

The first commercial sales of Spectral AI's DeepView wound imaging system for burns are due to start in the UK, its first market, later this year

Sales 122

Sales Marketing 122

Pharmaceutical Technology

APRIL 1, 2025

In 2025, the CNS market is forecast to surpass $80bn in sales for the first time since 2013, marking a significant turnaround.

Marketing 130

Marketing Sales 130

Pharmaceutical Technology

APRIL 28, 2023

Novo Nordisk’s leading drug Ozempic (semaglutide) is forecast to demonstrate a sales growth of 23% in 2023. Ozempic’s forecast 2023 sales of $12.5bn consolidate its position as the dominant market leader, with projected sales in 2023 54% greater than closest competitor Trulicity (dulaglutide) by Eli Lilly, which anticipates sales of $8bn.

Sales 130

Sales Insulin Marketing FDA Approval 130

Pharmaceutical Technology

NOVEMBER 21, 2022

Japan is currently the fourth largest market in the world. Based on GlobalData estimates, the Japanese pharmaceutical market generated JPY9.392 trillion ($67.32 billion) in total sales in 2021 and is expected to grow 1.1% Other reasons include lower sales demand and high investment costs.

Marketing 173

Marketing Sales Manufacturing Drugs 173

Fierce Pharma

AUGUST 7, 2024

In the second quarter, Tepezza generated $479 million in sales for an increase of 8% year over year and 13% sequentially. It was Tepezza’s highest quarterly sales figure since Q4 of 2022. Is the thyroid eye disease (TED) treatment finally gaining momentum that is sustainable?

Sales 94

Sales Marketing 94

Bio Pharma Dive

MARCH 17, 2023

The digital therapeutics firm is considering a sale, merger or other deal following struggles to market its app-based treatments.

Sales 246

Sales Marketing 246

Bio Pharma Dive

OCTOBER 31, 2023

The pharma’s shot Abrysvo made over $300 million in sales during the first few months of its launch, and will be an important product to help offset declining COVID vaccine sales.

Vaccination 180

Vaccination Vaccine Sales Marketing 180

Pharmaceutical Technology

FEBRUARY 14, 2025

The Duchenne muscular dystrophy (DMD) landscape across the seven major markets (7MM) - the US, France, Germany, Italy, Spain, the UK, and Japan - is projected to experience significant growth, with sales increasing from $2.3bn in 2023 to $5.2bn by 2033, according to leading data and analytics company GlobalData.

Marketing 147

Marketing Sales 147